Gwo-Jen Day
Advertisement
Gwo-Jen Day is a senior scientist at LamdaGen Corporation
Articles by Gwo-Jen Day
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Clears In-Vivo Gene Editing Therapy PBGENE-DMD for Duchenne Trial
2
European Commission Approves Uplizna as Add-On Therapy for Antibody-Positive Generalized Myasthenia Gravis
3
Preclinical Study Finds Subcutaneous Nanotrastuzumab Comparable to Herceptin HYLECTA in Minipig Model
4
The Clinical Execution Gap: Why Great Science Often Fails at the Trial Stage
5
